Payment overview · 2025
General Payments
$19.88
1 reported records · 1 companies
Healthcare provider profile · identity verified
Lauren Bell, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · WISCONSIN RAPIDS, WI · NPI 1144564170
Verified facts
What the public records show
CMS Open Payments records show Lauren Bell, ARNP received $19.88 in general payments during 2025 across 1 reported records.
Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $19.88 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.88 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 425 | 124 |
| Levothyroxine Sodium | Levothyroxine Sodium | 423 | 129 |
| Omeprazole | Omeprazole | 333 | 84 |
| Lisinopril | Lisinopril | 309 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 247 | 76 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 242 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 79 |
| Simvastatin | Simvastatin | 230 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 213 | 68 |
| Gabapentin | Gabapentin | 206 | 52 |
| Losartan Potassium | Losartan Potassium | 203 | 68 |
| Prednisone | Prednisone | 168 | 161 |
| Furosemide | Furosemide | 167 | 54 |
| Tramadol Hcl | Tramadol Hcl | 154 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 139 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 137 | 68 |
| Pantoprazole Sodium | Pantoprazole Sodium | 129 | 41 |
| Warfarin Sodium | Warfarin Sodium | 127 | 18 |
| Metformin Hcl | Metformin Hcl | 110 | 35 |
| Potassium Chloride | Potassium Chloride | 102 | 38 |
| Trazodone Hcl | Trazodone Hcl | 101 | 26 |
| Eliquis | Apixaban | 97 | 23 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 94 | 22 |
| Sertraline Hcl | Sertraline Hcl | 93 | 28 |
| Allopurinol | Allopurinol | 91 | 18 |
| Montelukast Sodium | Montelukast Sodium | 91 | 31 |
| Alendronate Sodium | Alendronate Sodium | 90 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 21 |
| Metformin Hcl Er | Metformin Hcl | 86 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 85 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 84 | 12 |
| Lorazepam | Lorazepam | 80 | 30 |
| Spironolactone | Spironolactone | 74 | 26 |
| Bupropion Xl | Bupropion Hcl | 72 | 19 |
| Atenolol | Atenolol | 71 | 23 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 71 | 26 |
| Cefdinir | Cefdinir | 67 | 62 |
| Clopidogrel | Clopidogrel Bisulfate | 66 | 16 |
| Methocarbamol | Methocarbamol | 65 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 64 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 59 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | 12 |
| Jardiance | Empagliflozin | 54 | 16 |
| Fenofibrate | Fenofibrate | 53 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 52 | suppressed |
| Clonazepam | Clonazepam | 51 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 51 | 27 |
| Famotidine | Famotidine | 50 | 12 |
| Clindamycin Hcl | Clindamycin Hcl | 49 | 47 |
| Paroxetine Hcl | Paroxetine Hcl | 48 | 11 |
| Glipizide Er | Glipizide | 45 | 14 |
| Pregabalin | Pregabalin | 45 | 21 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 43 |
| Ezetimibe | Ezetimibe | 43 | 15 |
| Mirtazapine | Mirtazapine | 42 | suppressed |
| Naproxen | Naproxen | 41 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 11 |
| Donepezil Hcl | Donepezil Hcl | 39 | suppressed |
| Meloxicam | Meloxicam | 39 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 22 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 38 | 23 |
| Carvedilol | Carvedilol | 36 | 11 |
| Levetiracetam | Levetiracetam | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 27 |
| Cephalexin | Cephalexin | 29 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 28 | 25 |
| Finasteride | Finasteride | 28 | suppressed |
| Lactulose | Lactulose | 28 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 26 | suppressed |
| Alprazolam | Alprazolam | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 14 |
| Meclizine Hcl | Meclizine Hcl | 21 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Nystatin | Nystatin | 20 | 14 |
| Ozempic | Semaglutide | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Comfort Ez Pro Safety Pen Ndl | Pen Needle, Diabetic, Safety | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | 13 |
| Invokana | Canagliflozin | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 12 |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.88 · 1 records | Gilead Sciences, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error